X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (173) 173
humans (162) 162
diabetes (124) 124
endocrinology & metabolism (109) 109
middle aged (104) 104
female (103) 103
male (102) 102
type 2 diabetes (96) 96
aged (77) 77
risk factors (75) 75
diabetes mellitus, type 2 - drug therapy (74) 74
abridged index medicus (64) 64
hypoglycemic agents - therapeutic use (60) 60
cardiovascular disease (52) 52
medicine, general & internal (49) 49
mortality (48) 48
mellitus (46) 46
diabetes mellitus, type 2 - blood (45) 45
cardiovascular diseases (43) 43
diabetes mellitus, type 2 - complications (43) 43
risk (43) 43
care and treatment (42) 42
glucose (42) 42
adult (41) 41
research (41) 41
clinical trials (39) 39
diabetes mellitus (39) 39
blood pressure (35) 35
double-blind method (33) 33
follow-up studies (33) 33
cardiac & cardiovascular systems (32) 32
insulin (32) 32
prevention (32) 32
drug therapy (30) 30
treatment outcome (30) 30
blood glucose - metabolism (27) 27
health risk assessment (27) 27
prospective studies (27) 27
diagnosis (26) 26
patient outcomes (25) 25
hyperglycemia (24) 24
hypoglycemic agents - adverse effects (24) 24
studies (24) 24
analysis (23) 23
cardiovascular diseases - prevention & control (23) 23
disease (22) 22
hypertension (22) 22
patients (22) 22
health aspects (21) 21
metformin - therapeutic use (21) 21
stroke (21) 21
complications (20) 20
incidence (20) 20
medical research (20) 20
diabetes mellitus, type 2 - epidemiology (19) 19
heart attacks (19) 19
myocardial infarction (19) 19
proportional hazards models (19) 19
cardiovascular diseases - epidemiology (18) 18
complications and side effects (18) 18
glycated hemoglobin a - metabolism (18) 18
hypoglycemic agents (18) 18
metformin (18) 18
blood glucose - drug effects (17) 17
glycated hemoglobin a - analysis (17) 17
trial (17) 17
united kingdom (17) 17
united kingdom - epidemiology (17) 17
diabetes therapy (16) 16
dosage and administration (16) 16
insulin - therapeutic use (16) 16
therapy (16) 16
type 2 diabetes mellitus (16) 16
body mass index (15) 15
diabetes mellitus, type 2 - physiopathology (15) 15
diabetic angiopathies - epidemiology (15) 15
hypoglycemic agents - administration & dosage (15) 15
metaanalysis (15) 15
nateglinide (15) 15
research design (15) 15
sitagliptin (15) 15
valsartan (15) 15
coronary-heart-disease (14) 14
dextrose (14) 14
diabetes complications (14) 14
drug therapy, combination (14) 14
follow-up (14) 14
heart diseases (14) 14
population (14) 14
prevalence (14) 14
risk-factors (14) 14
blood glucose (13) 13
cardiovascular-disease (13) 13
cholesterol (13) 13
death (13) 13
internal medicine (13) 13
outcomes (13) 13
randomized controlled trials as topic (13) 13
sulfonylurea compounds - therapeutic use (13) 13
blood glucose - analysis (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes Care, ISSN 0149-5992, 01/2009, Volume 32, Issue 1, pp. 193 - 203
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the... 
Journal Article
Diabetes Care, ISSN 0149-5992, 05/2008, Volume 31, Issue 5, pp. 845 - 851
Rosiglitazone-Associated Fractures in Type 2 Diabetes An analysis from A Diabetes Outcome Progression Trial (ADOPT) Steven E. Kahn , MB, CHB 1 , Bernard Zinman... 
Journal Article
Nature Reviews Endocrinology, ISSN 1759-5029, 02/2018, Volume 14, Issue 2, pp. 67 - 68
Journal Article
The Lancet, ISSN 0140-6736, 08/2019, Volume 394, Issue 10199, pp. 635 - 635
Journal Article
Diabetes, ISSN 0012-1797, 06/2019, Volume 68, Issue Supplement 1, p. 253
Background: Latent Autoimmune Diabetes of Adults (LADA) is a mild form of autoimmune diabetes which can be identified in 3-12% of adults who have a clinical... 
Diabetic retinopathy | Glutamic acid | Retinopathy | Autoantibodies | Diabetes mellitus | Lipids | Glutamate decarboxylase | Hemorrhage | Cholesterol | Glomerular filtration rate | Body mass index | Blindness | Renal failure | Blood pressure | Microvasculature | Diabetes | Diagnosis | Autoimmune diseases | Lipoproteins (high density) | Cytoplasm | Smoking
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 25, p. 2479
Journal Article
Diabetes, ISSN 0012-1797, 06/2019, Volume 68, Issue Supplement 1, p. 1479
Background and Aims: Heart failure (HF) is a deadly complication of type 2 diabetes but little is known about its incidence in patients with coronary heart... 
Heart failure | Myocardial infarction | Creatinine | Acarbose | Diabetes mellitus | Cardiovascular disease | Coronary artery disease | Glucose tolerance | Fibrillation | Death | Diabetes | Health risk assessment | Diabetes mellitus (non-insulin dependent) | Heart diseases | Smoking
Journal Article
Diabetes, ISSN 0012-1797, 06/2019, Volume 68, Issue Supplement 1, p. 2436
Background and Aims: Patients with cardiovascular disease are at high risk of type 2 diabetes (T2D), but little has been done to provide robust T2D risk... 
Acarbose | Calcium | Diabetes mellitus | Cardiovascular disease | Coronary artery disease | Glucose tolerance | Hyperglycemia | Prediction models | Diabetes | Cardiovascular diseases | Health risk assessment | Diabetes mellitus (non-insulin dependent) | Heart diseases
Journal Article
Diabetes Care, ISSN 0149-5992, 2019, Volume 42, Issue 6, p. E95
Journal Article
Nature Reviews Endocrinology, ISSN 1759-5029, 08/2014, Volume 10, Issue 8, pp. 453 - 454
Journal Article
Diabetes care, ISSN 0149-5992, 09/2018, Volume 41, Issue 9, pp. 1844 - 1853
OBJECTIVEThe choice of therapy for type 2 diabetes after metformin is guided by overall estimates of glycemic response and side effects seen in large cohorts.... 
INSULIN | METFORMIN | DESIGN | ENDOCRINOLOGY & METABOLISM | GLYCEMIC RESPONSE | FRACTURES | THERAPEUTIC RESPONSE | ROSIGLITAZONE | MELLITUS | OUTCOMES | ASSOCIATION | Hypoglycemia - epidemiology | Metformin - therapeutic use | Hypoglycemic Agents - economics | Primary Health Care - statistics & numerical data | Humans | Middle Aged | Diabetes Mellitus, Type 2 - economics | Male | Sulfonylurea Compounds - economics | Diabetes Mellitus, Type 2 - epidemiology | Metformin - economics | Thiazolidinediones - therapeutic use | Aged, 80 and over | Adult | Female | Hypoglycemia - economics | Hypoglycemia - chemically induced | Body Mass Index | Hypoglycemic Agents - therapeutic use | Randomized Controlled Trials as Topic - statistics & numerical data | Risk Assessment | Sulfonylurea Compounds - therapeutic use | Thiazolidinediones - economics | Datasets as Topic - statistics & numerical data | Blood Glucose - drug effects | Cost-Benefit Analysis | Sex Factors | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | United Kingdom - epidemiology | Type 2 diabetes | Complications and side effects | Body mass index | Analysis | Clinical trials | Research | Hypoglycemic sulfonylureas | Sulfonylurea compounds | Thiazolidinediones | Risk factors | Edema | Therapy | Diabetes mellitus | Sex | Risk | Hypoglycemia | Males | Patients | Subgroups | Weight | Side effects | Reduction | Body mass | Sulfonylurea | Rosiglitazone | Genetics | Research design | Diabetes | Metformin | Females | Diabetes mellitus (non-insulin dependent) | Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.